Company Login
Site Newsletter
Welcome to PharmiWeb.com
Latest Press Releases
- Successful Investigational New Drug application (IND) Review for Intravenous CP-4126
03 Jul 09
PharmiWeb.com - ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study with TB-402
03 Jul 09
PharmiWeb.com - Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer’s Immunotherapy Program and Equity Investment
03 Jul 09
PharmiWeb.com - Lundbeck's Lu AA24530 shows positive results in major depressive disorder phase II study
03 Jul 09
PharmiWeb.com - GSK further extends its product portfolio in the Middle East and North Africa
03 Jul 09
PharmiWeb.com
Latest News
Anuh Pharma - Demise of DirectorBusiness Today
04 Jul 09 , 09:23
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)Medical News Today
04 Jul 09 , 09:15
BioCis Pharma Reports Positive Phase IIa Clinical Results In Atopic DermatitisMedical News Today
04 Jul 09 , 09:14
IRELAND: Johnson & Johnson Buys Stake in Elan Corp (Subscribers Only Content)Kamcity
04 Jul 09 , 08:56
Maxygen to Form JV with Astellas to Develop Protein PharmaceuticalsIndividual.com
04 Jul 09 , 08:47
Latest Events
- Clinical Oncology
06 Jul 09 - 10 Jul 09 - THE MEDICAL DEVICE SUMMER SCHOOL - 5 Day Residential Course - London - From Concept to CE Marking
06 Jul 09 - 10 Jul 09 - INTRODUCTORY OVERVIEW OF THE PHARMA INDUSTRY
06 Jul 09 - 06 Jul 09
pharmiweb.com today | 04 July 2009
GSK moves further into Middle East and Africa
GlaxoSmithKline plc announced that it has acquired the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen for a cash consideration of $23.2m (£14.2m). The business comprises a portfolio of 13 branded pharmaceuticals with annual sales in 2008 of $11.8m. This purchase is another step forward in GSK’s strategy to accelerate growth in emerging markets and signals a strong commitment to provide quality medicines to patients in the Middle East and North Africa.
This acquisition builds upon GSK’s previous purchases of mature branded products in 2008 from BMS in Pakistan and Egypt, which included a high quality manufacturing plant in Giza, Greater Cairo. BMS will continue to supply the products acquired today until 2011 when it is anticipated that manufacture will transfer to GSK’s Giza plant.
Latest Features
Networking as a tool to help you find your next job in Clinical Research
02 Jul 09
Getting a job in Clinical research or Regulatory Affairs can be tough at the best of times.
World Vaccine Congress Asia: vast regional diversity requires flexibility and targeted portfolios
01 Jul 09
Spanning one third of the globe's circumference and home to more than half of the world's population, the Asia Pacific region is incredibly diverse.
The 10th Annual Congress of the European League Against Rheumatism (EULAR)
18 Jun 09
Field reporter Rhonda Siddall reports from EULAR
Latest Poll
